PMID- 33217860
OWN - NLM
STAT- MEDLINE
DCOM- 20201210
LR  - 20231112
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 99
IP  - 47
DP  - 2020 Nov 20
TI  - Effectiveness of cognitive behavioral therapy on kinesiophobia and oral 
      health-related quality of life in patients with temporomandibular disorders, 
      study protocol for a randomized controlled trial.
PG  - e23295
LID - 10.1097/MD.0000000000023295 [doi]
LID - e23295
AB  - BACKGROUND: Temporomandibular disorders (TMD) is a common physical and 
      psychological disease in dental department. Pain and mandibular limitation are 
      the main reasons for patients to seek oral treatment. However, the presence of 
      kinesiophobia, patients often catastrophize pain, so as to avoid mandibular 
      movement, which seriously affects their quality of life. Cognitive behavioral 
      therapy (CBT) has significant improvements in reducing kinesiophobia and quality 
      of life in musculoskeletal disease, but has not been proved in TMD patients. The 
      study aims to apply CBT on kinesiophobia and oral health related quality of life 
      (OHRQOL) in TMD patients. METHODS: A total of 108 individuals between 18 and 65 
      years of age, who will be referred to the temporomandibular joint clinic of 
      Stomatology Hospital of Tianjin Medical University in china will be randomized 
      into 2 treatment arms. The control group will receive a conventional treatment, 
      whereas the experiment group will receive CBT on the basis of the control group. 
      The primary outcomes will be the kinesiophobia and OHRQOL, and will be measured 
      by the Tampa scale for kinesiophobia for patients with Temporomandibular 
      Disorders (TSK-TMD) and the Oral Health Impact Scale for patients with 
      temporomandibular disorders (OHIP-TMDs), the secondary outcomes will be pain 
      intensity measured by Numerical Rating Scale (NRS), pain catastrophizing measured 
      by Pain Catastrophizing Scale (PCS), anxiety and depression measured by Hospital 
      Anxiety and Depression Scale (HADS), and self-efficacy measured by General 
      Self-Efficacy Scale (GSES). DISCUSSION: This study protocol reported a randomized 
      controlled trial which aimed at assessing the effectiveness of the CBT versus 
      conventional treatment with TMD. TRIAL REGISTRATION: Registered in the Chinese 
      Clinical Trial Registration Center with the number ChiCTR2000038573. Registered 
      24 September 2020.
FAU - Zhang, Qi
AU  - Zhang Q
AUID- ORCID: 0000-0002-8462-7382
AD  - School of Nursing, Tianjin University of Traditional Chinese Medicine.
FAU - Zhang, Juan
AU  - Zhang J
AD  - The TMJ Clinic, Stomatological Hospital of Tianjin Medical University.
FAU - Ran, Wenjing
AU  - Ran W
AD  - School of Nursing, Tianjin University of Traditional Chinese Medicine.
FAU - Yu, Shuipeng
AU  - Yu S
AD  - School of Stomatology, Tianjin Medical University.
FAU - Jin, Yingshu
AU  - Jin Y
AD  - Department of Nursing, Stomatological Hospital of Tianjin Medical University, 
      Tianjin, China.
LA  - eng
PT  - Clinical Trial Protocol
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - *Cognitive Behavioral Therapy
MH  - Humans
MH  - Movement
MH  - *Oral Health
MH  - Pain/*etiology/*psychology
MH  - Phobic Disorders/*therapy
MH  - *Quality of Life
MH  - Randomized Controlled Trials as Topic/*methods
MH  - Single-Blind Method
MH  - Temporomandibular Joint Disorders/*complications
MH  - Treatment Outcome
PMC - PMC7676583
COIS- The authors have no conflicts of interest.
EDAT- 2020/11/22 06:00
MHDA- 2020/12/15 06:00
PMCR- 2020/11/20
CRDT- 2020/11/21 01:00
PHST- 2020/11/21 01:00 [entrez]
PHST- 2020/11/22 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
PHST- 2020/11/20 00:00 [pmc-release]
AID - 00005792-202011200-00075 [pii]
AID - MD-D-20-09906 [pii]
AID - 10.1097/MD.0000000000023295 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2020 Nov 20;99(47):e23295. doi: 
      10.1097/MD.0000000000023295.